BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 19399343)

  • 1. DNA methylation profile in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesis.
    Bernal C; Vargas M; Ossandón F; Santibáñez E; Urrutia J; Luengo V; Zavala LF; Backhouse C; Palma M; Argandoña J; Aguayo F; Corvalán A
    Biol Res; 2008; 41(3):303-15. PubMed ID: 19399343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
    Chang MS; Uozaki H; Chong JM; Ushiku T; Sakuma K; Ishikawa S; Hino R; Barua RR; Iwasaki Y; Arai K; Fujii H; Nagai H; Fukayama M
    Clin Cancer Res; 2006 May; 12(10):2995-3002. PubMed ID: 16707594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprimo as a potential biomarker for early detection in gastric cancer.
    Bernal C; Aguayo F; Villarroel C; Vargas M; Díaz I; Ossandon FJ; Santibáñez E; Palma M; Aravena E; Barrientos C; Corvalan AH
    Clin Cancer Res; 2008 Oct; 14(19):6264-9. PubMed ID: 18829507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas.
    Oue N; Motoshita J; Yokozaki H; Hayashi K; Tahara E; Taniyama K; Matsusaki K; Yasui W
    J Pathol; 2002 Sep; 198(1):55-9. PubMed ID: 12210063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratified for Helicobacter pylori infection.
    Park SY; Yoo EJ; Cho NY; Kim N; Kang GH
    J Pathol; 2009 Dec; 219(4):410-6. PubMed ID: 19639607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
    Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
    Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
    Zhou YN; Xu CP; Han B; Ji R
    Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus.
    Kusano M; Toyota M; Suzuki H; Akino K; Aoki F; Fujita M; Hosokawa M; Shinomura Y; Imai K; Tokino T
    Cancer; 2006 Apr; 106(7):1467-79. PubMed ID: 16518809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies of promoter methylation status and protein expression of E-cadherin gene in associated progression stages of gastric cancer].
    Zheng ZH; Sun XJ; Ma MC; Hao DM; Liu YH; Sun KL
    Yi Chuan Xue Bao; 2003 Feb; 30(2):103-8. PubMed ID: 12776596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological significance of promoter hypermethylation of tumor-related genes in patients with gastric carcinoma.
    Ksiaa F; Ziadi S; Amara K; Korbi S; Trimeche M
    Clin Chim Acta; 2009 Jun; 404(2):128-33. PubMed ID: 19336228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent p16 CpG island hypermethylation in primary remnant gastric cancer suggesting an independent carcinogenic pathway.
    Mino A; Onoda N; Yashiro M; Aya M; Fujiwara I; Kubo N; Sawada T; Ohira M; Kato Y; Hirakawa K
    Oncol Rep; 2006 Mar; 15(3):615-20. PubMed ID: 16465421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers.
    Etoh T; Kanai Y; Ushijima S; Nakagawa T; Nakanishi Y; Sasako M; Kitano S; Hirohashi S
    Am J Pathol; 2004 Feb; 164(2):689-99. PubMed ID: 14742272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
    Oue N; Mitani Y; Motoshita J; Matsumura S; Yoshida K; Kuniyasu H; Nakayama H; Yasui W
    Cancer; 2006 Mar; 106(6):1250-9. PubMed ID: 16475210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma.
    Kang GH; Lee S; Kim WH; Lee HW; Kim JC; Rhyu MG; Ro JY
    Am J Pathol; 2002 Mar; 160(3):787-94. PubMed ID: 11891177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of E-cadherin hypermethylation to tumorigenesis and development of gastric cancer].
    Liu WT; Jiao HL; Yang YL; Wang D; Zhang WM
    Ai Zheng; 2007 Nov; 26(11):1199-203. PubMed ID: 17991318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of promoter polymorphism of nuclear factor-erythroid 2-related factor 2 gene on the aberrant DNA methylation in gastric epithelium.
    Arisawa T; Tahara T; Shibata T; Nagasaka M; Nakamura M; Kamiya Y; Fujita H; Yoshioka D; Arima Y; Okubo M; Hirata I; Nakano H
    Oncol Rep; 2008 Jan; 19(1):211-6. PubMed ID: 18097597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes.
    Matsusaka K; Kaneda A; Nagae G; Ushiku T; Kikuchi Y; Hino R; Uozaki H; Seto Y; Takada K; Aburatani H; Fukayama M
    Cancer Res; 2011 Dec; 71(23):7187-97. PubMed ID: 21990320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hierarchical clustering analysis to detect associations between clinical and pathological features of gastric tumors and hypermethylation of suppressor genes].
    Zavala G L; Luengo J V; Ossandón C F; Riquelme S E; Backhouse E C; Palma V M; Argandoña C J; Cumsille MA; Corvalán R A
    Rev Med Chil; 2007 Jan; 135(1):17-25. PubMed ID: 17369979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Promoter methylation profile in gastric cancer].
    Roa JC; Anabalón L; Roa I; Tapia O; Melo A; Villaseca M; Araya JC
    Rev Med Chil; 2005 Aug; 133(8):874-80. PubMed ID: 16163424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.